Selective Protein-Protein Interaction Screening With Modular Fusion Reporters
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods struggle to selectively disrupt protein-protein interactions with precision, which is crucial for controlling cellular functions and treating pathological conditions.
Innovation Solution
A method involving the expression of fusion proteins with DNA-binding moieties and gene activating moieties in a host cell, combined with a library of molecules to identify specific disruptors of protein interactions, using positive and negative selection reporters to ensure selective disruption.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional enzyme active-site/inhibitor-based drug development scheme is used, then drug development is straightforward, but selective disruption of precise protein-protein interactions is difficult to achieve
Solution Approach 1:
The screening system is segmented into distinct functional modules: fusion proteins with specific DNA-binding moieties (e.g., LexA, TetR) and activation domains (e.g., VP16, GAL4), separate reporter genes (e.g., GFP, RFP), and modular promoter elements. This segmentation allows independent optimization of each component and enables flexible assembly for different protein-protein interaction targets, thereby improving selectivity without overwhelming complexity.
Solution Approach 2:
DNA-binding moieties serve as intermediaries that translate protein-protein interaction events into specific DNA-binding events, which then activate or repress reporter gene expression. This intermediary mechanism provides a clear, measurable readout of interaction disruption while maintaining high selectivity through the specificity of DNA-protein recognition, resolving the contradiction between reliability and complexity.
2Manufacturing precision
If multiple fusion proteins with different DNA-binding moieties are expressed, then selective disruption capability is improved, but system complexity increases
Solution Approach 1:
The system employs universal building blocks: a limited set of well-characterized DNA-binding moieties (e.g., LexA, TetR, Gal4) and activation domains that can be combined with different proteins of interest. These universal components recognize specific promoter sequences and produce standardized reporter outputs, enabling precise disruption studies across multiple protein pairs without proportionally increasing system complexity. The same reporter genes (GFP, RFP) serve multiple functions across different interaction assays.
Data Source
AI summary
The present disclosure provides methods to identify peptides and small molecule moieties that are able to modulate protein-protein interactions (PPIs). Some moieties can disrupt specific PPIs within a complex, or disrupt variant-specific PPIs. Some moieties can alternatively bridge between two proteins in a protein-specific or a variant-specific manner. The methods described enable generation of compounds able to modulate PPI networks within cells with implications for drug development for pathological conditions.